SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-134252
Filing Date
2021-04-27
Accepted
2021-04-27 16:15:57
Documents
5
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d43806ddef14a.htm DEF 14A 374215
2 GRAPHIC g43806g37y26.jpg GRAPHIC 81188
3 GRAPHIC g43806g54g96.jpg GRAPHIC 120749
4 GRAPHIC g43806g58r98.jpg GRAPHIC 55345
5 GRAPHIC g43806g97r97.jpg GRAPHIC 20442
  Complete submission text file 0001193125-21-134252.txt   745943
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38886 | Film No.: 21859099
SIC: 2834 Pharmaceutical Preparations